Stocks and Investing
Stocks and Investing
Mon, April 1, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Joshua Dennerlein Upgraded (DOC) to Strong Buy and Increased Target to $25 on, Apr 1st, 2024
Joshua Dennerlein of B of A Securities, Upgraded "Healthpeak Properties, Inc." (DOC) to Strong Buy and Increased Target from $18 to $25 on, Apr 1st, 2024.
Joshua has made no other calls on DOC in the last 4 months.
There are 5 other peers that have a rating on DOC. Out of the 5 peers that are also analyzing DOC, 3 agree with Joshua's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Connor Siversky of "Wells Fargo" Initiated at Hold and Held Target at $19 on, Monday, March 25th, 2024
- Todd Thomas of "Keybanc" Downgraded from Buy to Hold on, Friday, January 5th, 2024
- Michael Lewis of "Truist Securities" Maintained at Hold with Decreased Target to $14 on, Friday, December 22nd, 2023
These are the ratings of the 2 analyists that currently disagree with Joshua
- Michael Carroll of "RBC Capital" Initiated at Buy and Held Target at $21 on, Friday, March 8th, 2024
- Merrill Ross of "Compass Point" Maintained at Strong Buy with Decreased Target to $18 on, Tuesday, January 2nd, 2024
Contributing Sources